Johnson & Johnson (JNJ) Non-cash Items (2010 - 2012)

Johnson & Johnson's (JNJ) quarterly Non-cash Items came in at $1.0 billion in Q1 2012, up 54.94% year-on-year from $648.0 million in Q1 2011, and up 54.94% quarter-over-quarter from $648.0 million in Q1 2011.

Johnson & Johnson (JNJ) Non-cash Items (2010 - 2012) Analysis & Trends

Johnson & Johnson has disclosed Non-cash Items across 3 years of filings, most recently posting $1.0 billion for Q1 2012.

  • Non-cash Items for Q1 2012 came in at $1.0 billion, up 54.94% year-over-year; the trailing twelve-month figure through Jan 2012 was $1.0 billion (up 54.94% YoY), and the FY2012 annual result was $1.0 billion, up 54.94% from the prior year.
  • Non-cash Items came in at $1.0 billion for Q1 2012 at Johnson & Johnson, up from $648.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.0 billion in Q1 2012 to a low of $148349.0 in Q1 2010.
  • The 3-year median for Non-cash Items is $648.0 million (2011), against an average of $550.7 million.
  • Across the five-year window, Non-cash Items soared 436707.8% in 2011 and soared 54.94% in 2012, its largest moves.
  • Johnson & Johnson's Non-cash Items stood at $148349.0 in 2010, then jumped by 436707.8% to $648.0 million in 2011, then jumped by 54.94% to $1.0 billion in 2012.
  • The last three Non-cash Items figures came in at $1.0 billion (Q1 2012), $648.0 million (Q1 2011), and $148349.0 (Q1 2010), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Jan 1, 2012 1.00 Bn
Jan 1, 2012 1.00 Bn
Jan 2, 2011 648.00 Mn
Jan 2, 2011 648.00 Mn
Jan 3, 2010 148,349.00
Jan 3, 2010 148,349.00